Newsletter | March 2, 2023

03.02.23 -- 6 Strategies To Protect Your Biologics Supply Chain In 2023

Featured Editorial
Industry Insights
Alternatives To In Vivo Assays For Biosafety Testing Of Biologics

Even as alternative methods such as PCR and NGS have emerged, in vivo tests have stubbornly remained a central part of testing. Here we examine current in vivo methods and explore modern alternatives.

Better Biotherapeutic Characterization For Improved Quality Control
Critical quality attributes (CQAs) are fundamental to regulatory compliance and typically include data on how the candidate interacts with target proteins, size, and purity. In addition, information on process-related CQAs such as protein integrity, homogeneity, presence of host cell proteins, and DNA are required. This poster booklet provides a snapshot on how different analytical technologies have been used to investigate aspects related to the efficacy, stability, and safety of therapeutic candidates.
News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.